Medicare Enrolled

Dr. Eduardo Escorcia,, MD

Anesthesiology · Dallas, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
110 EVANS MILL DR STE 803, Dallas, GA 30157
7709486824
In practice since 2006 (20 years)
NPI: 1730124413 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Escorcia, from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Escorcia,? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Escorcia,

Dr. Eduardo Escorcia, is an anesthesiology specialist in Dallas, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Escorcia, performed 2,989 Medicare services across 1,320 unique beneficiaries.

Between the years covered by Open Payments, Dr. Escorcia, received a total of $4,894 from 43 pharmaceutical and/or device companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Escorcia, is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in GA $4,894 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,989
Medicare services
Top 3% in GA for anesthesiology
1,320
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~149 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
515 $94 $397
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
428 $66 $282
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
407 $61 $188
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
326 $47 $191
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
150 $47 $220
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
140 $194 $601
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
125 $105 $629
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
113 $149 $725
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
102 $111 $355
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
99 $153 $470
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
83 $97 $635
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
82 $56 $368
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
63 $41 $162
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
60 $78 $502
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
54 $125 $523
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint.
47 $54 $306
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
33 $85 $339
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
33 $151 $580
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
31 $111 $814
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
28 $46 $189
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
27 $63 $439
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
23 $37 $145
Injection, methylprednisolone acetate, 40 mg 20 $4 $6
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,894
Total received (2018-2024)
Avg $699/year across 7 years
Top 7% in GA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
200
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,804 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$368
2023
$343
2022
$642
2021
$1,244
2020
$603
2019
$488
2018
$1,207

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BIOTRONIK NRO, Inc.
$86
Stryker Corporation
$59
Medtronic, Inc.
$50
Saluda Medical Americas, Inc.
$47
Boston Scientific Corporation
$41
Curonix LLC
$35
Abbott Laboratories
$23
Collegium Pharmaceutical, Inc.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$1,402
Abbott Laboratories
$680
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$367
VGI Medical, LLC
$273
Boston Scientific Corporation
$223
Collegium Pharmaceutical, Inc.
$209
Daiichi Sankyo Inc.
$198
BOSTON SCIENTIFIC CORPORATION
$156
Flexion Therapeutics, Inc.
$100
Medtronic USA, Inc.
$94
BIOTRONIK NRO, Inc.
$86
Forte Bio-Pharma LLC
$81
Medtronic, Inc.
$80
Stimwave Technologies Incorporated
$75
PFIZER INC.
$75
Purdue Pharma L.P.
$70
RedHill Biopharma Inc.
$62
Stryker Corporation
$59
Relievant Medsystems, Inc.
$59
Curonix LLC
$51
Saluda Medical Americas, Inc.
$47
BioDelivery Sciences International, Inc.
$43
Kaleo, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$30
Shionogi Inc
$24
ARBOR PHARMACEUTICALS, INC.
$24
Egalet US Inc
$23
Allergan Inc.
$22
Averitas Pharma Inc.
$20
Scilex Pharmaceuticals Inc.
$19
FORTE BIO-PHARMA LLC
$19
Amgen Inc.
$19
Flowonix Medical Incorporated
$18
Hikma Pharmaceuticals USA
$18
SCILEX PHARMACEUTICALS INC.
$17
ASSERTIO THERAPEUTICS, Inc.
$17
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$16
Almatica Pharma LLC
$16
Supernus Pharmaceuticals, Inc.
$15
Pernix Therapeutics Holdings, Inc.
$12
Sentynl Therapeutics, Inc.
$12
AstraZeneca Pharmaceuticals LP
$11
Amniox Medical, Inc.
$10
Top 3 companies account for 50.0% of all-time payments
Associated products mentioned in payments ›
Amitiza · BELBUCA · BOTOX THERAPEUTIC · Cambia · Evoke · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Kloxxado · LYRICA · Levorphanol · MILD DEVICE KIT · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NEOX · Nalocet · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · Prospera · QUTENZA · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SCS IPGs · SPRIX · SUPERION · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · SiJoin/VerteLoc · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Symproic · TROKENDI XR · WAVEWRITER ALPHA · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for anesthesiology in GA.

Looking for an anesthesiology specialist in Dallas?
Compare anesthesiologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
91
Per 100K population
52.2
County median income
$94,557
Nearest hospital
WELLSTAR PAULDING MEDICAL CENTER
6.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Escorcia, is a clinical cardiology specialist, with above-average Medicare volume (top 3% in GA), with low-engagement industry engagement in the top 7% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Escorcia, experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Escorcia, performed 515 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Escorcia, receive payments from pharmaceutical companies?
Yes. Dr. Escorcia, received a total of $4,894 from 43 companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Escorcia,'s costs compare to other anesthesiologists in Dallas?
Dr. Escorcia,'s average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Escorcia,) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →